Literature DB >> 12974944

Combined intravesical hyperthermia and mitomycin chemotherapy: a preliminary in vivo study.

Lea Rath-Wolfson1, Boaz Moskovitz, Yoram Dekel, Valentina Kugel, Rumelia Koren.   

Abstract

Previous clinical studies of the combination of local intravesical hyperthermia with cytostatic drugs for the treatment of Superficial Transitional Cell Carcinoma of the urinary bladder (STCCB) showed encouraging results both in reducing recurrence rate to 20-30% within 2 years and in ablative success rate of 79%. Our objectives were to evaluate bladder tissue and adjacent organs during and following hyperthermia treatment. An intravesical catheter equipped with a radio-frequency antenna (Synergo SB-TS 101.1 System) was used for hyperthermia and intravesical chemotherapy (mitomycin C) was instilled in vivo for 60 min in two anaesthetized sheep. Thirteen to fifteen thermocouples were sewn surgically on the internal and external surfaces of the bladder wall and on adjacent organs to monitor the temperature during the treatment. We expected the intravesical temperature to be under 46 degrees C and the external layers below 45 degrees C. The bladder was filled with 50 mL of chemotherapeutic solution (400 micro g/mL of mitomycin C in distilled water). The sheep were sacrificed at the end of the treatment. Three other sheep, which underwent thoracic surgery, served as control group. Histological changes in both groups showed foci of oedema and haemorrhage with inflammation in the lamina propria and serosa. Foci of desquamation of the epithelium were noticed in the treated sheep. Histological analysis of the treated group showed no significant differences from the control group. The control group showed similar changes, some less pronounced. The combined treatment of hyperthermia with mitomycin C did not cause major damage to the urinary bladder or adjacent organs. All changes were superficial and reversible, and the control group showed similar changes, some less pronounced. Although this is an experimental model based on one single session treatment, rather than repeated treatments, it suggests that the approach may be useful in future studies both in models and man.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12974944      PMCID: PMC2517551          DOI: 10.1046/j.1365-2613.2003.00346.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  12 in total

1.  [Study of the synergy of microwave hyperthermia/intravesical chemotherapy in the prevention of recurrences of superficial tumors of the bladder].

Authors:  B Mauroy; J L Bonnal; B Prevost; M Chive; V Lhotellier; J P Sozanski; L Vanseymortier; X Stefaniak
Journal:  Prog Urol       Date:  1999-02       Impact factor: 0.915

2.  Effect of local hyperthermia of the bladder on mitomycin C pharmacokinetics during intravesical chemotherapy for the treatment of superficial transitional cell carcinoma.

Authors:  R Paroni; A Salonia; A Lev; L F Da Pozzo; G Cighetti; F Montorsi; P Rigatti; R Colombo
Journal:  Br J Clin Pharmacol       Date:  2001-09       Impact factor: 4.335

3.  Local microwave hyperthermia and intravesical chemotherapy as bladder sparing treatment for select multifocal and unresectable superficial bladder tumors.

Authors:  R Colombo; L F Da Pozzo; A Lev; A Salonia; P Rigatti; Z Leib; C Servadio; E Caldarera; M Pavone-Macaluso
Journal:  J Urol       Date:  1998-03       Impact factor: 7.450

4.  Thermo-chemotherapy and electromotive drug administration of mitomycin C in superficial bladder cancer eradication. a pilot study on marker lesion.

Authors:  R Colombo; M Brausi; L Da Pozzo; A Salonia; F Montorsi; V Scattoni; M Roscigno; P Rigatti
Journal:  Eur Urol       Date:  2001-01       Impact factor: 20.096

5.  Pathological effects of hyperthermia in normal tissues.

Authors:  L F Fajardo
Journal:  Cancer Res       Date:  1984-10       Impact factor: 12.701

6.  Non-invasive molecular detection of bladder cancer recurrence.

Authors:  Najla Amira; Samia Mourah; François Rozet; Pierre Teillac; Jean Fiet; Philippe Aubin; Ariane Cortesse; François Desgrandchamps; Alain Le Duc; Olivier Cussenot; Hany Soliman
Journal:  Int J Cancer       Date:  2002-09-20       Impact factor: 7.396

7.  Synergism between alkylating agent and cis-platin with moderate local hyperthermia: the effect of multidrug chemotherapy in an animal system.

Authors:  S Matsushita; R Reynolds; M Urano
Journal:  Int J Hyperthermia       Date:  1993 Mar-Apr       Impact factor: 3.914

8.  A new approach using local combined microwave hyperthermia and chemotherapy in superficial transitional bladder carcinoma treatment.

Authors:  R Colombo; A Lev; L F Da Pozzo; M Freschi; G Gallus; P Rigatti
Journal:  J Urol       Date:  1995-03       Impact factor: 7.450

9.  Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: results of a randomized trial with epirubicin comparing short-term versus long-term maintenance treatment.

Authors:  Koichiro Nomata; Mitsuru Noguchi; Hiroshi Kanetake; Nobuo Tsuda; Mikio Hayashi; Shuji Yamashita; Tsutomu Sakuragi; Yasuyuki Kusaba; Kazuhiko Shindo
Journal:  Cancer Chemother Pharmacol       Date:  2002-08-24       Impact factor: 3.333

10.  Patterns of multiple recurrences of superficial (Ta/T1) transitional cell carcinoma of bladder and effects of clinicopathologic and biochemical factors.

Authors:  Yan Yan; Gerald L Andriole; Peter A Humphrey; Adam S Kibel
Journal:  Cancer       Date:  2002-09-15       Impact factor: 6.860

View more
  5 in total

Review 1.  Heating technology for malignant tumors: a review.

Authors:  H Petra Kok; Erik N K Cressman; Wim Ceelen; Christopher L Brace; Robert Ivkov; Holger Grüll; Gail Ter Haar; Peter Wust; Johannes Crezee
Journal:  Int J Hyperthermia       Date:  2020       Impact factor: 3.914

2.  Combination intravesical hyperthermia and chemotherapy for bladder cancer.

Authors:  Jessie L S Au; M Guillaume Wientjes
Journal:  Oncology (Williston Park)       Date:  2010-11-15       Impact factor: 2.990

3.  The effect of thermochemotherapy with mitomycin C on normal bladder urothelium, an experimental study.

Authors:  Murat Uçar; Muammer Altok; Mehmet Umul; Dilek Bayram; İlkay Armağan; Mustafa Güneş; Tahsin Çapkin; Sedat Soyupek
Journal:  Int Urol Nephrol       Date:  2016-01       Impact factor: 2.370

4.  A scalable hyperthermic intravesical chemotherapy (HIVEC) setup for rat models of bladder cancer.

Authors:  J W Van Hattum; E M Scutigliani; R F C P A Helderman; R Zweije; H M Rodermond; A L Oei; J Crezee; J R Oddens; T M De Reijke; P M Krawczyk
Journal:  Sci Rep       Date:  2022-04-29       Impact factor: 4.996

5.  The influence of thermo-chemotherapy on bladder tumours: an immunohistochemical analysis.

Authors:  Antoine G van der Heijden; Christina A Hulsbergen-Van de Kaa; J Alfred Witjes
Journal:  World J Urol       Date:  2007-02-14       Impact factor: 4.226

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.